UM171 Cell Therapy | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

117,063 results for “UM171 Cell Therapy”

Trials

View all 86678 →

Active, not recruiting

UM171 Expanded Cord Blood In Patients With High-Risk Acute Leukemia/Myelodysplasia

30 participants · First posted Apr 12, 2019

ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma

19 participants · First posted Feb 22, 2018

US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia

30 participants · First posted Sep 26, 2019

Drugs

View all 7132 →

Anti-EPCAM CAR-T cell therapy (Sinobioway)

autologous stem cell therapy

NK cell therapy

Organizations

View all 221 →

Cell Therapy Ltd.

United Kingdom

Juventas Cell Therapy Ltd

China

Shanghai Cell Therapy Research Institute

China

News

View all 23032 →

Zemcelpro Receives NUB Status 1 in Germany, Enabling Immediate Hospital Reimbursement Applications

ExCellThera's Zemcelpro Receives Positive CHMP Opinion for Blood Cancer Patients Without Suitable Donors

BlueRock Therapeutics' Cell Therapy Shows Promise in Phase I Parkinson's Disease Trial

Page 1 of 11707